Patent details
EP3229828 Title: INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION
Basic Information
- Publication number:
- EP3229828
- PCT Application Number:
- EP2015079285
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP158081778
- PCT Publication Number:
- WO2016092026
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION
- French Title of Invention:
- FORMULATION À RAPPORT FIXE D'INSULINE GLARGINE/LIXISENATIDE
- German Title of Invention:
- INSULIN-GLARGIN/LIXISENATID-FIXIERTE VERHÄLTNISFORMULIERUNG
- SPC Number:
Dates
- Filing date:
- 10/12/2015
- Grant date:
- 05/04/2023
- EP Publication Date:
- 18/10/2017
- PCT Publication Date:
- 16/06/2016
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/04/2023
- EP B1 Publication Date:
- 05/04/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 10/12/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 29/03/2023
- Name:
- Sanofi-Aventis Deutschland GmbH
- Address:
- Brüningstraße 50, 65929 Frankfurt am Main, Germany (DE)
Agent
- Name:
- ARONOVA S.A.
- From:
- 14/06/2023
- Address:
- PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
- To:
Inventor
1
- Name:
- SOUHAMI, Elisabeth
- Address:
- France (FR)
2
- Name:
- SILVESTRE, Louise
- Address:
- France (FR)
Priority
1
- Priority Number:
- 14197685
- Priority Date:
- 12/12/2014
- Priority Country:
- European Patent Office (EPO) (EP)
2
- Priority Number:
- 15193940
- Priority Date:
- 10/11/2015
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61K 38/26; A61K 38/28; A61P 3/10;
Publication
European Patent Bulletin
- Issue number:
- 202314
- Publication date:
- 05/04/2023
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 31/12/2026
- Annual Fee Number:
- 12
- Annual Fee Amount:
- 165 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 28/11/2025
- Last Annual Fee Paid Number:
- 11
- Last Annual Fee Paid Amount:
- 148 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 14/06/2023 | Power Of Attorney | 1 |
| 15/06/2023 | Outgoing Correspondence | 1 |